Results: Among 45 adult CMT1A patients, 42% had been diagnosed after 50 years of age, whereas 91% of all patients had exhibited some CMT-related symptoms before 20 years of age. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease.